Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4QG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,894
Award facts
- Contract value 100% obligated
- $3,893.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,893.76 under a firm fixed-price contract. This delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The product will be delivered from the company's facility in Conshohocken, Pennsylvania, with a completion date of December 9, 2025.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates delivery capabilities across a wide spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies. As the prime contractor on this delivery order, AmerisourceBergen continues to support Department of Defense healthcare operations through its comprehensive pharmaceutical supply agreement, which enables flexible fulfillment of medical commodity requirements for military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FZ4QG?
SPE2DR26FZ4QG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FZ4QG worth?
The government has obligated $3,894 on SPE2DR26FZ4QG.
Is contract SPE2DR26FZ4QG an order under another contract?
Yes. SPE2DR26FZ4QG is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4QG competed?
The extent of competition for SPE2DR26FZ4QG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award